NCT06595784Recruiting
The HELlenic Thoracic Society Initiative for CΟPD and CVD
Source: ClinicalTrials.gov · Last updated 16 Sept 2026
Brief summary (registry, in English)
COPD is one of the most common respiratory diseases in Greece, and maybe more than half a million Greek citizens suffer both from COPD and CVD, however their characteristics and management remain unknown. HELICOPD is a national, multicenter, prospective, non-interventional study designed to contribute to better understanding and depicting the demographic and clinical characteristics of this population, the COPD- and CVD-related adverse events in a two-years period, their quality of life and the healthcare resources use. The study is initiated and coordinated by the Hellenic Thoracic Society.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 900 (estimated)
- First submitted
- 5 Sept 2024
- Start date
- 15 Oct 2024
- Primary completion date
- Oct 2026
- Lead sponsor
- Hellenic Thoracic Society
- Diseases
- COPD
- NCT number
- NCT06595784
What you commit to
- Study type: Observational
- Planned participants: 900
- From 15 Oct 2024 to the primary completion date, Oct 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Patients should cumulatively meet the following three (3) criteria to be enrolled in the study:
- To have been diagnosed with chronic obstructive pulmonary disease and at least one cardiovascular comorbidity (heart failure, atherosclerotic cardiovascular disease, atrial Fibrillation, severe valvular disease)
- Adults aged \>35 years at the time of inclusion in the study,
- With signed informed consent for their participation in the study. Exclusion criteria Patients with the below limitations are not eligible to participate in the study
- Patients:
- Without at least one cardiovascular comorbidity,
- With history of lung cancer
- With any other active malignancy and undergoing treatment (chemotherapy/radiotherapy/immunotherapy)
- With any thoracic or abdominal surgery planned during study follow-up period
- With participation in any COPD-related interventional study at study entry or during study duration.
- Without signed informed consent for their participation in the study.
Age in the registry: 35 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Respiratory Medicine, Medical School, Democritus University of Thrace, University General Hospital Coordinator of this site? Confirm its status | Alexandroupoli | Greece | Recruiting |
| 5th Pulmonary Department, "Sotiria" Chest Diseases Hospital, Athens, Greece Coordinator of this site? Confirm its status | Athens | Greece | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.